Table 4.
Postoperative clinical outcome
| No post-CPB LV dysfunction (n = 56) | With post-CPB LV dysfunction (n = 38) | P value | |
|---|---|---|---|
| In-Hospital Mortality (%) | 3.6 | 18.4* | 0.044 |
| Adverse Cardiac events (%) | |||
| Myocardial Infarct (%) | 0 | 13.2* | 0.022 |
| Arrhythmia's (%) | 19.6 | 50* | 0.029 |
| Low Cardiac Output (%) | 1.8 | 60.5* | <0.001 |
| Wound infection (%) | 3.6 | 5.3 | 0.665 |
| Pneumonia (%) | 3.6 | 7.9 | 0.368 |
| Re-operation (%) | 8.9 | 5.3 | 0.773 |
| Duration of Mechanical Ventilation (h) | 9 (7) | 38 (28)* | 0.032 |
| Peak Serum Troponin (ng/L) | 1.7 (1.2) | 12.3 (9.2)* | 0.026 |
| Peak Serum Creatinin (mg/L) | 88 (24) | 102 (46) | 0.092 |
| Duration of stay in ICU (d) | 3.1 (1.5) | 6.9 (5.5)* | <0.001 |
| Duration of stay in Hospital (d) | 10 (3) | 14 (7)* | 0.022 |
LV, left ventricular; CPB, cardiopulmonary bypass.
*P < 0.05, between the two groups; χ2 test with Yates correction or unpaired Student t test.